HNSBF - Hansa Biopharma to Host Conference Call to Provide Interim Results for the First Nine Months of 2019 and Business Update
LUND, Sweden, Oct. 11, 2019 /PRNewswire/ -- Hansa Biopharma will publish its interim report for the first nine months of 2019 at 8:00 a.m. CET on October 31, 2019. All interested parties are invited to participate in a telephone conference, which will include a presentation of the interim results and a business update, on the same date at 1:00 p.m. CET. The event will be hosted by Hansa Biopharma's CEO, Søren Tulstrup, and CFO, Donato Spota, and the presentation will be held in English.
Slides used in the presentation will be live on the company website during the call under "Events & Webcast," and will also be made available online after the call. To participate in the telephone conference, please use the dial-in details provided below:
Dial-in numbers for participants:
SE: +46-8-566-42-661
UK: +44-203-19-40-544
US: +1-855-26-92-604
For additional international numbers, please refer to the complete list on https://livehouseeurope.com/telco_price/#tab-62e38f57f1bfadb16f0.
The webcast will be available on https://hansa.eventcdn.net/2019q3/.
For further information, please contact:
Klaus Sindahl
Head of Investor Relations
Hansa Biopharma
Mobile: +46(0)709-298-269
E-mail: klaus.sindahl@hansabiopharma.com
Rolf Gulliksen
Head of Corporate Communications
Hansa Biopharma
Mobile: +46(0)733-328-634
E-mail: rolf.gulliksen@hansabiopharma.com
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Hansa Biopharma to host conference call to provide interim results for the first nine months of 2019 and business update |
SOURCE Hansa Biopharma AB